Immunogenicity of SARS-CoV-2 Vaccination Schedules Including a Booster Dose in Patients with Systemic Lupus Erythematosus: Data from a Prospective Multicenter Study

In patients with SLE, SARS-CoV-2 vaccines are immunogenic, inducing a robust humoral response. No severe outcomes associated with death or hospitalization were found in the evaluated patient sample. Complete vaccination schedules including a booster dose induced higher humoral responses than incomplete schedules, especially in patients initially immunized with an inactivated virus vaccine schedule and those with a suboptimal humoral response.

Authors

Institutions

Publication Details

Journal
Vaccines
Published
2025-01-27
DOI
https://doi.org/10.3390/vaccines13020127
Citations
3
Primary Topic
SARS-CoV-2 and COVID-19 Research
Type
article
Field-Weighted Citation Impact
4.19

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Immunogenicity of SARS-CoV-2 Vaccination Schedules Including a Booster Dose in Patients with Systemic Lupus Erythematosus: Data from a Prospective Multicenter Study

Viviane Angelina de Souza, Rodrigo Cutrim Gaudio, Erika Biegelmeyer, Bruna Guimarães Dutra et al.
3 citations
Vaccines
SARS-CoV-2 and COVID-19 Research
4.19
article

Immunogenicity of SARS-CoV-2 Vaccination Schedules Including a Booster Dose in Patients with Systemic Lupus Erythematosus: Data from a Prospective Multicenter Study

Viviane Angelina de Souza, Rodrigo Cutrim Gaudio, Erika Biegelmeyer, Bruna Guimarães Dutra, Vanessa Hax, Jozélia Rêgo, Natália Sarzi Sartori, Renata Henriques de Azevedo, Emília Inoue Sato, Gilda Aparecida Ferreira, Alexandre Wagner Silva de Souza, Valderílio Feijó Azevedo, Valéria Valim, Vanessa Peruhype-Magalhães, Vítor Alves Cruz, Cristiane Kayser, Marcos Mavignier Sousa Dias, Ketty Lysie Libardi Lira Machado, Paula dos Santos Athayde, Luiza Lorenzoni Grillo, J. Rodrigues, Mariana Freitas de Aguiar, Sérgio Henrique Oliveira dos Santos, Camila Maria Paiva França Telles, Victória Dornelas Paz Carvalho, Vanessa de Oliveira Magalhães, Gecilmara Salviato Pileggi, Priscila Dias Cardoso Ribeiro, Odirlei André Monticielo, Samira Tatiyama Miyamoto, Helena da Silva Corona, Charlles Heldan de Moura Castro, Valéria Bezerra da Silva, Maria da Penha Gomes Gouvea, Adriana María Kakehasi, Flávia Maria Matos Melo Campos Peixoto, Ana Paula Neves Burian, Samuel Elias Basualto Dias, Adah Sophia Rodrigues Vieira, Andrese Aline Gasparin, Marcelo M. Pinheiro, Sandra Lúcia Euzébio Ribeiro, Rodrigo Poubel Vieira de Rezende, Ana Karla Guedes de Melo, Juliana Bühring, Filipe Faé, Ricardo Machado Xavier, Edgard Torres dos Reis-Neto, Rejane Maria Rodrigues de Abreu Vieira, Kátia Lino, F. Z. Pretti, Clara Pinheiro Martins, Anna Carolina Faria Moreira Gomes Tavares, Olindo Assis Martins-Filho, Vasco Silva, Andréa Teixeira-Carvalho, Sabrina de Souza Ramos, Karina Rosemarie Lallemand Tapia, Anna Carolina Simões Moulin, Yasmin Gurtler Pinheiro de Oliveira
article en
3 citations

Abstract

In patients with SLE, SARS-CoV-2 vaccines are immunogenic, inducing a robust humoral response. No severe outcomes associated with death or hospitalization were found in the evaluated patient sample. Complete vaccination schedules including a booster dose induced higher humoral responses than incomplete schedules, especially in patients initially immunized with an inactivated virus vaccine schedule and those with a suboptimal humoral response.

VaccinesVol. 13(2)
Universidade Federal de Juiz de Fora (BR), Universidade Federal de Minas Gerais (BR), Universidade Federal do Rio Grande do Sul (BR), Universidade Federal Fluminense (BR), Universidade Federal da Paraíba (BR), Universidade de Fortaleza (BR), Hospital de Clínicas de Porto Alegre (BR), Hospital Universitário Lauro Wanderley (BR), Instituto de Saúde (BR), Hospital das Clínicas da Universidade Federal de Minas Gerais (BR), Secretaria da Saúde (BR), Universidade Federal do Espírito Santo (BR), Fundação Oswaldo Cruz (BR), Universidade Federal do Amazonas (BR), Universidade Federal de Goiás (BR), Universidade Federal de São Paulo (BR)
Fundação Oswaldo Cruz
Good health and well-being
Openalex Percentile: Top 8%
SARS-CoV-2 and COVID-19 Research
4.19
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.